Trilogy valve demonstrates safety and effectiveness in treating aortic regurgitation
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the…